Scleroderma News

The FDA has granted breakthrough designation to a novel investigational therapy, BI 1015550, for treatment of patients with idiopathic pulmonary fibrosis, according to a press release from Boehringer Ingelheim.

Nintedanib slows the rate of forced vital capacity decline in patients with fibrosing autoimmune disease-related interstitial lung disease, with adverse events manageable for most, according to data published in Arthritis & Rheumatology.

Lack of antibody response following COVID-19 vaccination is the strongest predictor of breakthrough infection in patients with autoimmune rheumatic disease, according to data published in Annals of the Rheumatic Diseases.

Every so often, autoimmunity hits the mainstream media. Usually this happens when a celebrity bravely uses their place in the limelight to raise awareness by publicly sharing news about their diagnosis.

Vasodilator therapy may be underused for Raynaud’s phenomenon and very early systemic sclerosis in U.S. veterans deployed in post-9/11 military operations, according to data published in BMC Rheumatology.

One out of three registered randomized controlled trials on connective tissue diseases are never completed or published, representing a “waste of energy or resources” that may skew meta-analyses, according to researchers.

Kristin B. Highland, MD, does it all and makes it look easy. In this episode, we discuss how to follow your dreams, balance your life and define success on your own terms.

Just 0.7% of fully vaccinated patients with inflammatory rheumatic and musculoskeletal disease experience a breakthrough COVID-19 infection, while only 4.4% demonstrate disease flare reactions, according to data.

Among patients with systemic sclerosis, occupational exposure to toxicants independently predicted decline in lung function, regardless of sex, researchers reported in Chest.

Patients with rare autoimmune rheumatic diseases have a 54% increased risk for COVID-19 infection, and more than twice the risk for COVID-19 death, versus the general population, according to data published in Rheumatology.